Gates Foundation Pledges $5.7M Toward Ebola Treatment Trials

News outlets report on the Bill & Melinda Gates Foundation’s pledge of $5.7 million to test experimental Ebola treatments in West Africa.

BBC News: Ebola outbreak: $5.7m pledged for blood plasma trials
“The Bill & Melinda Gates Foundation has pledged $5.7m towards a program to increase production of experimental Ebola treatments in Guinea and other affected countries…” (11/18).

Bloomberg News: Gates to Fund Ebola Survivor Blood, Chimerix Drug Trials
“The Bill & Melinda Gates Foundation committed $5.7 million to help produce and test potential blood-based therapies and antiviral treatments for Ebola. The funds will support efforts in West Africa to evaluate plasma and other blood products from survivors of Ebola virus disease as a means of treating the infection in others, the Seattle-based foundation said in an e-mailed Nov. 18 statement. Various drug candidates will also be tested, including Chimerix Inc. (CMRX)’s antiviral brincidofovir…” (Gale, 11/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.